The abstract is read at the publisher; the summary is JClub's.
PMOS affects 10–13% of reproductive-age women and is linked to MASLD and type 2 diabetes through shared metabolic and hormonal mechanisms across female life stages.
- Why it matters: MASLD and type 2 diabetes are common globally, but women’s risk is shaped by PMOS and hormonal transitions, leaving a gap in life stage–tailored screening and early intervention.
- What they did: This narrative review consolidates epidemiological and mechanistic evidence connecting MASLD, type 2 diabetes, and PMOS, emphasizing pathways such as hyperandrogenism, insulin resistance, and chronic inflammation.
- The result: The review highlights experimental models and suggests that adolescence, pregnancy, and menopause are windows of vulnerability, informing screening and early intervention strategies to reduce long-term cardiometabolic and liver morbidity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.